Renaissance Technologies’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $451K | Buy |
1,882,860
+69,000
| +4% | +$16.5K | ﹤0.01% | 2885 |
|
|
2025
Q1 | $357K | Sell |
1,813,860
-712,664
| -28% | -$140K | ﹤0.01% | 2861 |
|
|
2024
Q4 | $1.36M | Buy |
2,526,524
+869,949
| +53% | +$469K | ﹤0.01% | 2307 |
|
|
2024
Q3 | $1.57M | Sell |
1,656,575
-129,766
| -7% | -$123K | ﹤0.01% | 2168 |
|
|
2024
Q2 | $1.74M | Buy |
1,786,341
+394,566
| +28% | +$385K | ﹤0.01% | 1959 |
|
|
2024
Q1 | $2.2M | Buy |
1,391,775
+21,536
| +2% | +$34K | ﹤0.01% | 1972 |
|
|
2023
Q4 | $1.09M | Buy |
1,370,239
+342,379
| +33% | +$272K | ﹤0.01% | 2352 |
|
|
2023
Q3 | $802K | Sell |
1,027,860
-478,515
| -32% | -$373K | ﹤0.01% | 2448 |
|
|
2023
Q2 | $1.39M | Buy |
1,506,375
+1,323,675
| +725% | +$1.22M | ﹤0.01% | 2236 |
|
|
2023
Q1 | $199K | Sell |
182,700
-378,273
| -67% | -$412K | ﹤0.01% | 3282 |
|
|
2022
Q4 | $819K | Sell |
560,973
-5,259
| -0.9% | -$7.68K | ﹤0.01% | 2653 |
|
|
2022
Q3 | $609K | Buy |
566,232
+56,232
| +11% | +$60.5K | ﹤0.01% | 2809 |
|
|
2022
Q2 | $867K | Sell |
510,000
-449,703
| -47% | -$764K | ﹤0.01% | 2812 |
|
|
2022
Q1 | $1.98M | Buy |
959,703
+532,016
| +124% | +$1.1M | ﹤0.01% | 2242 |
|
|
2021
Q4 | $1.6M | Buy |
+427,687
| New | +$1.6M | ﹤0.01% | 2317 |
|
|
2021
Q3 | – | Sell |
-303,495
| Closed | -$1.29M | – | 3421 |
|
|
2021
Q2 | $1.29M | Buy |
303,495
+202,495
| +200% | +$863K | ﹤0.01% | 2528 |
|
|
2021
Q1 | $536K | Sell |
101,000
-791,095
| -89% | -$4.2M | ﹤0.01% | 2883 |
|
|
2020
Q4 | $4.81M | Sell |
892,095
-429,516
| -32% | -$2.31M | 0.01% | 1611 |
|
|
2020
Q3 | $10.5M | Sell |
1,321,611
-383,800
| -23% | -$3.06M | 0.01% | 1091 |
|
|
2020
Q2 | $17.1M | Sell |
1,705,411
-44,549
| -3% | -$446K | 0.01% | 914 |
|
|
2020
Q1 | $4.76M | Buy |
1,749,960
+284,817
| +19% | +$775K | ﹤0.01% | 1598 |
|
|
2019
Q4 | $1.76M | Buy |
1,465,143
+586,384
| +67% | +$704K | ﹤0.01% | 2382 |
|
|
2019
Q3 | $1.33M | Buy |
878,759
+381,659
| +77% | +$576K | ﹤0.01% | 2480 |
|
|
2019
Q2 | $2M | Sell |
497,100
-297,400
| -37% | -$1.2M | ﹤0.01% | 2329 |
|
|
2019
Q1 | $3.42M | Buy |
794,500
+168,200
| +27% | +$723K | ﹤0.01% | 2042 |
|
|
2018
Q4 | $3.6M | Sell |
626,300
-407,500
| -39% | -$2.34M | ﹤0.01% | 1934 |
|
|
2018
Q3 | $14M | Sell |
1,033,800
-268,307
| -21% | -$3.64M | 0.01% | 1136 |
|
|
2018
Q2 | $15.5M | Sell |
1,302,107
-3,893
| -0.3% | -$46.2K | 0.02% | 1093 |
|
|
2018
Q1 | $14.7M | Buy |
1,306,000
+312,000
| +31% | +$3.5M | 0.02% | 1128 |
|
|
2017
Q4 | $6.64M | Sell |
994,000
-161,100
| -14% | -$1.08M | 0.01% | 1631 |
|
|
2017
Q3 | $9.46M | Buy |
1,155,100
+85,800
| +8% | +$703K | 0.01% | 1364 |
|
|
2017
Q2 | $4.8M | Buy |
1,069,300
+288,500
| +37% | +$1.3M | 0.01% | 1741 |
|
|
2017
Q1 | $4.3M | Buy |
780,800
+335,700
| +75% | +$1.85M | 0.01% | 1780 |
|
|
2016
Q4 | $1.8M | Buy |
445,100
+116,400
| +35% | +$472K | ﹤0.01% | 2280 |
|
|
2016
Q3 | $2.32M | Buy |
328,700
+139,500
| +74% | +$983K | ﹤0.01% | 2101 |
|
|
2016
Q2 | $1.54M | Buy |
189,200
+76,000
| +67% | +$619K | ﹤0.01% | 2344 |
|
|
2016
Q1 | $920K | Buy |
113,200
+83,900
| +286% | +$682K | ﹤0.01% | 2637 |
|
|
2015
Q4 | $353K | Buy |
+29,300
| New | +$353K | ﹤0.01% | 2838 |
|